Navigation Links
Innovative and Forward-Thinking Experts to Deliver Keynote Presentations at IBC's 13th Annual Drug Discovery & Development of Innovative Therapeutics World Congress
Date:5/7/2008

Presenters include David M. Mott from MedImmune Inc., Elliott Sigal, M.D., Ph.D, from Bristol-Myers Squibb Company, Federico Goodsaid, Ph.D from the

FDA, and Mark Ratner from FDC_Windhover

WESTBOROUGH, Mass., May 7 /PRNewswire/ -- IBC Life Sciences announced the keynote line up for the 13th Annual Drug Discovery & Development of Innovative Therapeutics World Congress, to take place August 4-7, 2008 in Boston, MA. The keynote presentations will include speakers David M. Mott from MedImmune Inc. and Elliott Sigal, M.D., Ph.D, from Bristol-Myers Squibb Company. Keynote panel discussions this year will be led by Federico Goodsaid, Ph.D from the FDA, and Mark Ratner from FDC Windhover.

The two individual keynote speakers will discuss the scientific and business strategies that are necessary to move to clinical POC quickly. Keynote panel discussions will approach the more "controversial" topics such as the FDA position on biomarkers and the impact of the 2008 elections on the future of the pharmaceutical/healthcare industry. Presentations include:

4:20 PM, Tuesday, August 5:

Keynote speaker David M. Mott, Chief Executive Officer and President, MedImmune, Inc. will present "Risk-Taking & Innovation in Biotechnology: The MedImmune Success Story."

5:00 PM, Tuesday, August 5:

Keynote panel discussion "Biomarker Qualification in Drug Development: A Regulatory/Industry Discussion" will be led by Federico Goodsaid, Ph.D., Associate Director for Operations in Genomics, Office of Clinical Pharmacology, Office of Translational Sciences, CDER, FDA.

11:20 AM, Wednesday, August 6:

Keynote speaker Elliott Sigal, M.D., Ph.D. Executive Vice President, Chief Scientific Officer and President, Research & Development, Bristol-Myers Squibb Company will discuss "BioPharma of the Future: Blending the Best to Create the Next."

12:00 PM, Wednesday, August 6:

Keynote panel discussion "Leading in a Sea of
'/>"/>

SOURCE IBC Life Sciences
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. New TUMS(R) QuikPak(TM) Campaign Offers Innovative Heartburn Relief with a Little Help from the Jetsons
2. BioSpace and IBC Life Sciences Announce Career Fair Alliance For Drug Discovery & Development of Innovative Therapeutics World Congress
3. Sigma(R) Launches Innovative ChIP Kit Technology For Epigenetic Research
4. Bon MOT: Innovative atom trap catches highly magnetic atoms
5. Monogram HIV Antibody Assay Is Key Component of Innovative Vaccine Development Program
6. Bayer HealthCare Pharmaceuticals Introduces VistaTrak(TM) an Innovative Contrast Media Management System
7. CV Therapeutics and Medlogics Device Corporation Sign Licensing Agreement for CVTs Innovative Stent Coating Technology
8. Angiotech Submits 510(K) To FDA For Its Innovative 5-FU CVC
9. A&G Pharmaceutical Receives $870,000 Grant from Avon Foundation to Advance Innovative Blood Diagnostic Test for Early Detection of Breast Cancer
10. Ferndale and Foamix Enter Development of an Innovative Foam for the Treatment of Atopic Dermatitis
11. Innovative Fosshield(R) Antimicrobial Technology Shown to Continuously Kill MRSA Superbug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)...  Multiple new research abstracts suggest walnuts may have ... From their impact on colon cancer and certain aspects ... gut health and vascular health, the research findings presented ... of walnuts, inner workings. Running March 28 through April ... meeting attracts an international audience of over 14,000 leading ...
(Date:3/30/2015)... -- US-Australian drug discovery company, Novogen Ltd, (ASX:NRT; NASDAQ: ... Yale University, on March 27 released pre-clinical data on ... an oral presentation by Professor Gil Mor ... nd Annual Scientific Meeting of the Society of ... In both in vitro and in ...
(Date:3/30/2015)... , March 30, 2015  Spherix Incorporated ... committed to the fostering and monetization of intellectual ... VTech,  Case No. 3:13-cv-03494-M and  Spherix v. Uniden ... States District Court for the Northern District of ... regarding Spherix v. Verizon, Case No. ...
(Date:3/30/2015)... -- Richmond Pharmacology nimmt weltweit den ... das erste Zentrum weltweit, das in Zusammenarbeit mit ... London in einer weltweiten ... einem Patienten begonnen hat. Das Therapeutikum wurde für ... einer seltenen Herz- und Nervenkrankheit. ...
Breaking Biology Technology:New Findings Support the Benefits of Eating Walnuts on Overall Health 2New Findings Support the Benefits of Eating Walnuts on Overall Health 3New Findings Support the Benefits of Eating Walnuts on Overall Health 4Yale University and Novogen Release Data on Cantrixil Mode of Action 2Yale University and Novogen Release Data on Cantrixil Mode of Action 3Yale University and Novogen Release Data on Cantrixil Mode of Action 4Spherix Provides Update on Litigation vs. VTech, Uniden and Verizon 2Spherix Provides Update on Litigation vs. VTech, Uniden and Verizon 3
... and Company,(NYSE: LLY ) announced today that its ... for all outstanding,shares of ImClone Systems Incorporated (Nasdaq: ... in cash. Lilly and ImClone previously announced that they ... ImClone., The Board of Directors of ImClone has ...
... NLTX ), today announced interim data from its multi-center,open-label Phase ... patients hospitalized for acute heart failure., -- ... pressure -- Statistically significant increase in ... pressure -- Trend toward increase in cardiac output ...
... release date, NATICK, Mass., Oct. 14 ... the following comments reinforcing,the strength of its balance ... and the Company,s stock price,volatility have had no ... performance of the Company. Strong cash flow generation,during ...
Cached Biology Technology:Lilly Commences Cash Tender Offer for ImClone Systems at $70 Per Share 2Lilly Commences Cash Tender Offer for ImClone Systems at $70 Per Share 3Lilly Commences Cash Tender Offer for ImClone Systems at $70 Per Share 4Nile Therapeutics Announces Positive Interim Data from Phase 2a Study of CD-NP in Patients with Heart Failure 2Nile Therapeutics Announces Positive Interim Data from Phase 2a Study of CD-NP in Patients with Heart Failure 3Nile Therapeutics Announces Positive Interim Data from Phase 2a Study of CD-NP in Patients with Heart Failure 4Nile Therapeutics Announces Positive Interim Data from Phase 2a Study of CD-NP in Patients with Heart Failure 5Boston Scientific Provides Comments Reinforcing Strength of Its Balance Sheet 2Boston Scientific Provides Comments Reinforcing Strength of Its Balance Sheet 3
(Date:3/24/2015)... --  NexID Biometrics LLC, whose spoof-mitigation technology boosts ... the beginning of shipments of version 2.0 of its ... based in Potsdam, N.Y. , is ... began here today at the Walter E. Washington Convention ... SDK boosts the accuracy rate range to 96.5 to ...
(Date:3/23/2015)... SoundView Technology Group issues a new research update ... Wocket smart wallet. SoundView was one of the selected user groups ... the Wocket in multiple scenarios and outlets. ... retailers, making both debit and credit card payments.  ... the company meets their plans in 2015, it would push ...
(Date:3/23/2015)...  In the 2014 fiscal year, irs.gov recorded over ... figure accounts for a fraction of the estimated losses ... exceeds $11 billion globally. The polygraph has traditionally been ... occurred. Investor Mark Saint Juste along with ... partnered to administer the test in a new ...
Breaking Biology News(10 mins):NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 3Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 4Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3
... Technology has awarded almost $100,000 as part of its ... in NJIT,s high technology business incubator. Applechem ... located in NJIT,s Enterprise Development Center (EDC), each received ... Center works hard to help young inventors wend their ...
... CHAMPAIGN, Ill. Women taking aromatase inhibitors to treat ... before also taking a soy-based dietary supplement, researchers report. ... of estrogen in the body, can negate the effectiveness ... levels of estrogens that can promote tumor growth in ...
... colleagues have completed the genome sequence and genetic map ... plant parasites - Meloidogyne hapla , a microscopic, ... nematode. The research could help lead to a ... parasitic worm, which, along with other species of root-knot ...
Cached Biology News:Exciting new companies at NJIT's small biz incubator get 100K in grants 2The dietary supplement genistein can undermine breast cancer treatment 2The dietary supplement genistein can undermine breast cancer treatment 3NC State researchers get to root of parasite genome 2NC State researchers get to root of parasite genome 3
Autoclavable, variable volumefitted w./ an anti-drip safety valve; borosilicate glass barrelprotected with transparentpolypropylene sleeve; spring-lock cursor design ensuresfine adjustment for exact ...
Spaced cover glasses to promote effective hybridization...
Disposable tips with floating filter (US Patent 6,702,990) for PDM1.5 OneTouch Plus spotpicker, 10 racks of 96, DNAse and RNAse free...
... new D-LUX Detection Platform combines robust ... the most sensitive, specific, and cost-effective ... D-LUX Detection Platform offers exceptional performance ... TaqMan probes, high signal/background ratio, and ...
Biology Products: